However, since most naïve cells in COVID-19 patients gain this phenotype, we consider it unlikely that this is driven by antigen-specific memory development, but rather that CXCR4 may prime naïve T cells for trafficking to the lungs of COVID-19 patients (27). This evidence concerns the gene CXCR4 and COVID-19.